Twist Bioscience Corp Stock
Price
Target price
€103.50
€103.50
3.500%
3.5
3.500%
€102.62
14:24 / Tradegate
WKN: A2N7L2 / Symbol: TWST / Name: Twist Bioscience / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Twist Bioscience Corp Stock
Twist Bioscience Corp dominated the market today, gaining €3.50 (3.500%).
With 16 Buy predictions and not the single Sell prediction the community is currently very high on Twist Bioscience Corp.
However, we have a potential of -1.45% for Twist Bioscience Corp as the target price of 102 € is below the current price of 103.5 €.
Criterium "Revenue growth" is seen as the biggest plus for Twist Bioscience Corp stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Twist Bioscience Corp in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
S********** s********
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Twist Bioscience Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Twist Bioscience Corp | 3.500% | 25.849% | 27.877% | 353.926% | 259.066% | 369.043% | 6.090% |
| Pacira Pharmaceuticals | -0.930% | -7.018% | -5.357% | 6.000% | -1.852% | -38.728% | -58.431% |
| Corcept Therapeutics Inc. | 0.940% | -3.486% | 17.777% | 54.317% | 40.099% | 242.143% | 426.374% |
| Supernus Pharmaceuticals | 0.000% | -3.109% | -15.000% | 6.857% | -13.023% | 27.211% | 66.964% |
Comments
Twist Bioscience (TWST) had its "overweight" rating reaffirmed by Piper Sandler.
Show more
Ratings data for TWST provided by MarketBeat
Twist Bioscience (TWST) had its price target raised by Robert W. Baird from $113.00 to $115.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for TWST provided by MarketBeat
Twist Bioscience (TWST) had its "buy" rating reaffirmed by TD Cowen.
Show more
Ratings data for TWST provided by MarketBeat
